Alexandre Gouzy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandre Gouzy has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Sabine Ehrt
Department of Microbiology and Immunology, Weill Cornell Medicine
7 shared publications - Claire Marie Healy
School of Dental Science, Dublin Dental University Hospital, Trinity College Dublin , Dublin
3 shared publications - Dirk Schnappinger
Department of Microbiology and Immunology, Weill Cornell Medicine, New York, USA
3 shared publications Claire Healy
School of Medicine, Trinity College Dublin
2 shared publicationsJanïs Laudouze
Aix Marseille Univ, CNRS, LISM, IMM FR3479, IM2B, Marseille, France
2 shared publicationsKyu Y. Rhee
Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, 10065, USA
2 shared publications
Latest Publications
- Open Access
Non-canonical peptidoglycan cross-linking is essential for Mycobacterium tuberculosis acid resistance
Mycobacterium tuberculosis withstands acidic conditions to survive and replicate within macrophages. To define the genetic determinants of this adaptation, we performed a transposon screen in a lipid-rich, acidic medium that mimics the host environment and supports robust M. tuberculosis growth. This screen identified ldtB , encoding an L,D-transpeptidase, as essential for growth and survival under acid stress. Loss of LdtB decreased 3–3 peptidoglycan cross-linking, disrupted cell wall architecture, and impaired intrabacterial pH homeostasis, resulting in increased susceptibility to cell wall–active antibiotics. Notably, M. tuberculosis lacking LdtB displayed heightened sensitivity to meropenem within macrophages, suggesting that targeting this enzyme could potentiate β-lactam efficacy during infection. These findings establish LdtB as a key mediator linking peptidoglycan homeostasis to acid stress resistance and underscores the importance of in vitro culture models that recapitulate the host microenvironment for uncovering new in vivo active therapeutic targets. Teaser: Disabling a key peptidoglycan cross-linking enzyme compromises M. tuberculosis survival under acidic stress and antibiotic exposure.
Open AccessNon-canonical peptidoglycan cross-linking is essential for Mycobacterium tuberculosis acid resistance
Mycobacterium tuberculosis withstands acidic conditions to survive and replicate within macrophages. To define the genetic determinants of this adaptation, we performed a transposon screen in a lipid-rich, acidic medium that mimics the host environment and supports robust M. tuberculosis growth. This screen identified ldtB , encoding an L,D-transpeptidase, as essential for growth and survival under acid stress. Loss of LdtB decreased 3–3 peptidoglycan cross-linking, disrupted cell wall architecture, and impaired intrabacterial pH homeostasis, resulting in increased susceptibility to cell wall–active antibiotics. Notably, M. tuberculosis lacking LdtB displayed heightened sensitivity to meropenem within macrophages, suggesting that targeting this enzyme could potentiate β-lactam efficacy during infection. These findings establish LdtB as a key mediator linking peptidoglycan homeostasis to acid stress resistance and underscores the importance of in vitro culture models that recapitulate the host microenvironment for uncovering new in vivo active therapeutic targets. Teaser: Disabling a key peptidoglycan cross-linking enzyme compromises M. tuberculosis survival under acidic stress and antibiotic exposure.
- Open Access
Metabolic control of drug resistance by a mycobacterial ion channel
Pyrazinamide (PZA) is a cornerstone of modern tuberculosis therapy. Yet its activity is highly context-dependent and poorly captured by standard in vitro assays, complicating both mechanistic studies and the detection of resistance. To address this gap, we develop a lipid-rich, acidic culture system that more closely recapitulates the host infection environment and enables robust, reproducible in vitro measurement of PZA activity. Using this platform, we demonstrate that acidic pH is essential for PZA-mediated killing, independent of bacterial replication. Integrating this system with genome-wide CRISPR interference profiling, comparative genomics, and metabolomics, we identify the previously uncharacterized ion channel Rv2571c as a clinically relevant determinant of PZA susceptibility. Rv2571c is structurally homologous to plant anion channels and facilitates the net efflux of α-ketoglutarate, a central TCA cycle metabolite. We show that α-ketoglutarate export sensitizes Mtb to PZA-induced cytoplasmic acidification, a critical step in bacterial killing. Loss of Rv2571c function confers PZA resistance in vitro , during macrophage infection, and in mice, whereas increased channel expression results in hypersusceptibility. Together, these findings reveal a metabolite-driven mechanism that links ion channel activity, central carbon metabolism, and cytoplasmic pH homeostasis to antibiotic susceptibility, providing a framework for improved detection of PZA resistance and the rational development of PZA-like therapeutics that shorten treatment.
Open AccessMetabolic control of drug resistance by a mycobacterial ion channel
Pyrazinamide (PZA) is a cornerstone of modern tuberculosis therapy. Yet its activity is highly context-dependent and poorly captured by standard in vitro assays, complicating both mechanistic studies and the detection of resistance. To address this gap, we develop a lipid-rich, acidic culture system that more closely recapitulates the host infection environment and enables robust, reproducible in vitro measurement of PZA activity. Using this platform, we demonstrate that acidic pH is essential for PZA-mediated killing, independent of bacterial replication. Integrating this system with genome-wide CRISPR interference profiling, comparative genomics, and metabolomics, we identify the previously uncharacterized ion channel Rv2571c as a clinically relevant determinant of PZA susceptibility. Rv2571c is structurally homologous to plant anion channels and facilitates the net efflux of α-ketoglutarate, a central TCA cycle metabolite. We show that α-ketoglutarate export sensitizes Mtb to PZA-induced cytoplasmic acidification, a critical step in bacterial killing. Loss of Rv2571c function confers PZA resistance in vitro , during macrophage infection, and in mice, whereas increased channel expression results in hypersusceptibility. Together, these findings reveal a metabolite-driven mechanism that links ion channel activity, central carbon metabolism, and cytoplasmic pH homeostasis to antibiotic susceptibility, providing a framework for improved detection of PZA resistance and the rational development of PZA-like therapeutics that shorten treatment.
- Open Access
Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification
Pyrazinamide (PZA) is a cornerstone drug in tuberculosis (TB) treatment with a strong bactericidal activity in vivo on both actively and non-replicating bacterial subpopulations. Yet the precise mode of action of its active form, pyrazinoic acid (HPOA), remains unclear. In this study, we comprehensively explore and challenge the two major and conflicted models of PZA mode of action. The pH-dependent model, where the drug is mostly effective at acidic pH by acidifying Mycobacterium tuberculosis ( Mtb ) cytosol, and the PanD-dependent model where PZA’s active form targets the aspartate decarboxylase PanD, therefore depleting pantothenate and subsequently coenzyme A (CoA) levels regardless of the surrounding pH. By combining standard antimicrobial susceptibility testing at various pH with fluorescence-based live recording of Mtb intrabacterial pH, we demonstrate that PZA kills Mtb by decreasing intrabacterial pH, independently of pantothenate levels. Comparative studies between a prototrophic Mtb strain and a pantothenate auxotrophic mutant lacking the panCD locus confirmed that PZA bactericidal activity is primarily driven by pH and its ability to acidify Mtb cytosol, independently of the aspartate decarboxylase PanD. Bio-electrophysiology experiments revealed that acidic pH promotes the conversion of the pyrazinoate anion POA⁻ into HPOA which in turn acts as conventional weak acid that facilitates membrane permeation and cytosolic acidification. Finally, using custom-based culture media, we demonstrate that PZA displays heterogeneous efficacy according to the media composition, therefore proposing a revisited biological model that might explain the discrepancies around PZA’s unique mode of action. Overall, this work constitutes the first comprehensive side-by-side investigation of the two models and univocally supports a pH-dependent mechanism of action underlying PZA sterilizing activity, providing new insights for the development of more effective PZA-like drugs.
Open AccessPyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification
Pyrazinamide (PZA) is a cornerstone drug in tuberculosis (TB) treatment with a strong bactericidal activity in vivo on both actively and non-replicating bacterial subpopulations. Yet the precise mode of action of its active form, pyrazinoic acid (HPOA), remains unclear. In this study, we comprehensively explore and challenge the two major and conflicted models of PZA mode of action. The pH-dependent model, where the drug is mostly effective at acidic pH by acidifying Mycobacterium tuberculosis ( Mtb ) cytosol, and the PanD-dependent model where PZA’s active form targets the aspartate decarboxylase PanD, therefore depleting pantothenate and subsequently coenzyme A (CoA) levels regardless of the surrounding pH. By combining standard antimicrobial susceptibility testing at various pH with fluorescence-based live recording of Mtb intrabacterial pH, we demonstrate that PZA kills Mtb by decreasing intrabacterial pH, independently of pantothenate levels. Comparative studies between a prototrophic Mtb strain and a pantothenate auxotrophic mutant lacking the panCD locus confirmed that PZA bactericidal activity is primarily driven by pH and its ability to acidify Mtb cytosol, independently of the aspartate decarboxylase PanD. Bio-electrophysiology experiments revealed that acidic pH promotes the conversion of the pyrazinoate anion POA⁻ into HPOA which in turn acts as conventional weak acid that facilitates membrane permeation and cytosolic acidification. Finally, using custom-based culture media, we demonstrate that PZA displays heterogeneous efficacy according to the media composition, therefore proposing a revisited biological model that might explain the discrepancies around PZA’s unique mode of action. Overall, this work constitutes the first comprehensive side-by-side investigation of the two models and univocally supports a pH-dependent mechanism of action underlying PZA sterilizing activity, providing new insights for the development of more effective PZA-like drugs.
- Open Access
- 11 July 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (8) , e0006025
Identifying genetic determinants of Mycobacterium tuberculosis acid growth arrest by transposon mutagenesis coupled with next-generation sequencing (Tn-seq)
Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading global infectious disease killer. Adaptation of Mycobacterium tuberculosis to acidic niches within the host during infection is vital to establish the disease. Here, we present a high-density transposon mutant sequencing library data set identifying genetic determinants of acid growth arrest to serve as a resource.
- 11 July 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (8) , e0006025
Open AccessIdentifying genetic determinants of Mycobacterium tuberculosis acid growth arrest by transposon mutagenesis coupled with next-generation sequencing (Tn-seq)
Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading global infectious disease killer. Adaptation of Mycobacterium tuberculosis to acidic niches within the host during infection is vital to establish the disease. Here, we present a high-density transposon mutant sequencing library data set identifying genetic determinants of acid growth arrest to serve as a resource.
- Open Access
- 24 February 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (12) , 1634-1648
Unraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms
Mycobacterium tuberculosis (Mtb) is a successful pathogen that has developed a variety of strategies to survive and replicate within host cells. Among them, resistance mechanisms that allow Mtb to cope with the acidic environment of the endolysosomal network play a crucial role in its host adaptation and pathogenesis. In this Review, we summarize our understanding regarding the molecular factors contributing to Mtb acid resistance and the maintenance of intrabacterial pH homeostasis within in vitro and in cellulo systems. We also discuss some of the recently emerged concepts regarding host adaptation to acid stress, with a special emphasis on central carbon metabolism. Finally, we introduce some of the current and future direction(s) in this fast‐evolving field of research.
- 24 February 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (12) , 1634-1648
Open AccessUnraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms
Mycobacterium tuberculosis (Mtb) is a successful pathogen that has developed a variety of strategies to survive and replicate within host cells. Among them, resistance mechanisms that allow Mtb to cope with the acidic environment of the endolysosomal network play a crucial role in its host adaptation and pathogenesis. In this Review, we summarize our understanding regarding the molecular factors contributing to Mtb acid resistance and the maintenance of intrabacterial pH homeostasis within in vitro and in cellulo systems. We also discuss some of the recently emerged concepts regarding host adaptation to acid stress, with a special emphasis on central carbon metabolism. Finally, we introduce some of the current and future direction(s) in this fast‐evolving field of research.
- Open Access
- 8 January 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (1) , e0282524
An exacerbated phosphate starvation response triggers Mycobacterium tuberculosis glycerol utilization at acidic pH
The mechanisms controlling Mycobacterium tuberculosis (Mtb) replication and survival inside its human host remain ill-defined. Phagosome acidification and nutrient deprivation are common mechanisms used by macrophages to restrict the replication of intracellular bacteria. Mtb stops replicating at mildly acidic pH (pstA1 , a gene coding for a subunit of the Pst-1 system, results in the overexpression of the Pi starvation regulator regX3, which is sufficient to restore Mtb growth in acid conditions. Our data further support the role of limited glycerol uptake and ROS-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition in causing Mtb acid growth arrest. This study reveals an unexpected role of the Pi starvation response in regulating acid growth arrest and highlights the intricacy of the mechanisms regulating redox homeostasis, acid stress response, and nutrient utilization in Mtb. IMPORTANCE: Despite the availability of antibiotic treatment, M. tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a major infectious disease killer worldwide. A better understanding of the environments that Mtb faces during infection and the mechanisms Mtb employs to respond and adapt may help identify currently unexplored pathways and targets for the development of novel anti-TB drugs. Here, we demonstrate that Mtb growth in acid can be restored by the over-expression of the Pi starvation response regulator regX3 . This work paves the way toward a better understanding of the mechanisms controlling Mtb growth at acidic pH and highlights the role of inorganic phosphate in this process.
- 8 January 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (1) , e0282524
Open AccessAn exacerbated phosphate starvation response triggers Mycobacterium tuberculosis glycerol utilization at acidic pH
The mechanisms controlling Mycobacterium tuberculosis (Mtb) replication and survival inside its human host remain ill-defined. Phagosome acidification and nutrient deprivation are common mechanisms used by macrophages to restrict the replication of intracellular bacteria. Mtb stops replicating at mildly acidic pH (pstA1 , a gene coding for a subunit of the Pst-1 system, results in the overexpression of the Pi starvation regulator regX3, which is sufficient to restore Mtb growth in acid conditions. Our data further support the role of limited glycerol uptake and ROS-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition in causing Mtb acid growth arrest. This study reveals an unexpected role of the Pi starvation response in regulating acid growth arrest and highlights the intricacy of the mechanisms regulating redox homeostasis, acid stress response, and nutrient utilization in Mtb. IMPORTANCE: Despite the availability of antibiotic treatment, M. tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a major infectious disease killer worldwide. A better understanding of the environments that Mtb faces during infection and the mechanisms Mtb employs to respond and adapt may help identify currently unexplored pathways and targets for the development of novel anti-TB drugs. Here, we demonstrate that Mtb growth in acid can be restored by the over-expression of the Pi starvation response regulator regX3 . This work paves the way toward a better understanding of the mechanisms controlling Mtb growth at acidic pH and highlights the role of inorganic phosphate in this process.
- Open Access
- 26 October 2023
- Published by American Society for Microbiology in mSystems
- Vol. 8 (5) , e0073023
Use of single-cell technology to improve our understanding of the role of TLR2 in macrophage– Mycobacterium tuberculosis interaction
The interaction between Mycobacterium tuberculosis , the agent of tuberculosis (TB), and its host cell, the macrophage, is multifaceted, dynamic, and involves multiple molecular partners. A better understanding of this interaction could help researchers manipulate the immune system in order to design host-targeted immunotherapies and/or develop a novel vaccine protecting better adults against TB. Jani and coworkers studied the role of the macrophage receptor TLR2 in the response to M. tuberculosis using single-cell technologies (C. Jani, S. L. Solomon, J. M. Peters, and S. C. Pringle, et al., mSystems, https://doi.org/10.1128/msystems.00052-23 , 2023). This work addresses the multiple challenges associated with such studies and shows how informative single-cell analysis can be for the study of heterogeneous and complex host-pathogen interactions.
- 26 October 2023
- Published by American Society for Microbiology in mSystems
- Vol. 8 (5) , e0073023
Open AccessUse of single-cell technology to improve our understanding of the role of TLR2 in macrophage– Mycobacterium tuberculosis interaction
The interaction between Mycobacterium tuberculosis , the agent of tuberculosis (TB), and its host cell, the macrophage, is multifaceted, dynamic, and involves multiple molecular partners. A better understanding of this interaction could help researchers manipulate the immune system in order to design host-targeted immunotherapies and/or develop a novel vaccine protecting better adults against TB. Jani and coworkers studied the role of the macrophage receptor TLR2 in the response to M. tuberculosis using single-cell technologies (C. Jani, S. L. Solomon, J. M. Peters, and S. C. Pringle, et al., mSystems, https://doi.org/10.1128/msystems.00052-23 , 2023). This work addresses the multiple challenges associated with such studies and shows how informative single-cell analysis can be for the study of heterogeneous and complex host-pathogen interactions.
- Open Access
Reliable detection of pyrazinamide antitubercular activity in vitro
Pyrazinamide (PZA) is a pivotal antibiotic for the chemotherapy of tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb). PZA is notorious for its poor in vitro activity which complicates phenotypic PZA-susceptibility testing (PPST) and likely causes inappropriate treatment of TB patients. Here, we show that PZA activity can be reliably detected using an acidic and lipid-rich culture medium mimicking conditions Mtb encounters during an infection. Our growth model could facilitate PPST to improve the treatment of TB patients and ameliorate the global surveillance of PZA resistance.
Open AccessReliable detection of pyrazinamide antitubercular activity in vitro
Pyrazinamide (PZA) is a pivotal antibiotic for the chemotherapy of tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb). PZA is notorious for its poor in vitro activity which complicates phenotypic PZA-susceptibility testing (PPST) and likely causes inappropriate treatment of TB patients. Here, we show that PZA activity can be reliably detected using an acidic and lipid-rich culture medium mimicking conditions Mtb encounters during an infection. Our growth model could facilitate PPST to improve the treatment of TB patients and ameliorate the global surveillance of PZA resistance.
- Open Access
- 22 April 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-11
CinA mediates multidrug tolerance in Mycobacterium tuberculosis
The ability of Mycobacterium tuberculosis (Mtb) to resist and tolerate antibiotics complicates the development of improved tuberculosis (TB) chemotherapies. Here we define the Mtb protein CinA as a major determinant of drug tolerance and as a potential target to shorten TB chemotherapy. By reducing the fraction of drug-tolerant persisters, genetic inactivation of cinA accelerated killing of Mtb by four antibiotics in clinical use: isoniazid, ethionamide, delamanid and pretomanid. Mtb ΔcinA was killed rapidly in conditions known to impede the efficacy of isoniazid, such as during nutrient starvation, during persistence in a caseum mimetic, in activated macrophages and during chronic mouse infection. Deletion of CinA also increased in vivo killing of Mtb by BPaL, a combination of pretomanid, bedaquiline and linezolid that is used to treat highly drug-resistant TB. Genetic and drug metabolism studies suggest that CinA mediates drug tolerance via cleavage of NAD-drug adducts.
- 22 April 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-11
Open AccessCinA mediates multidrug tolerance in Mycobacterium tuberculosis
The ability of Mycobacterium tuberculosis (Mtb) to resist and tolerate antibiotics complicates the development of improved tuberculosis (TB) chemotherapies. Here we define the Mtb protein CinA as a major determinant of drug tolerance and as a potential target to shorten TB chemotherapy. By reducing the fraction of drug-tolerant persisters, genetic inactivation of cinA accelerated killing of Mtb by four antibiotics in clinical use: isoniazid, ethionamide, delamanid and pretomanid. Mtb ΔcinA was killed rapidly in conditions known to impede the efficacy of isoniazid, such as during nutrient starvation, during persistence in a caseum mimetic, in activated macrophages and during chronic mouse infection. Deletion of CinA also increased in vivo killing of Mtb by BPaL, a combination of pretomanid, bedaquiline and linezolid that is used to treat highly drug-resistant TB. Genetic and drug metabolism studies suggest that CinA mediates drug tolerance via cleavage of NAD-drug adducts.
- 24 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (621) , eabg2612
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected
Mycobacterium tuberculosis that sustains moderate oxidative damage survives undetected on solid media, but growth delay restores replicative ability.
- 24 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (621) , eabg2612
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected
Mycobacterium tuberculosis that sustains moderate oxidative damage survives undetected on solid media, but growth delay restores replicative ability.